FDA Warning Letter — Changzhou Jintan Qianyao Pharmaceutical Raw Materials
The FDA took a Warning Letter action against Changzhou Jintan Qianyao Pharmaceutical Raw Materials on May 11, 2017 (Jintan, China). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Changzhou Jintan Qianyao Pharmaceutical Raw Materials
- Date
- May 11, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Jintan (China)